Women's Health News

RSS

EpiGen to collaborate with Nestl- Research Center in Switzerland

The EpiGen Consortium, an international alliance of the world's leading epigenetics researchers (Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR), National University of Singapore, University of Southampton, Medical Research Council - Lifecourse Epidemiology Unit, AgResearch Limited, Auckland UniServices Limited) are pleased to announce the creation of a research collaboration with Nestl- Research Center in Switzerland.

23 Nov 2011

Virtues of a simple “Thank You” a day

Gratitude is a positive emotion with strong psychological effects say researchers. Now psychologists are trying to figure out the brain chemistry behind gratitude and the best ways of showing it.

22 Nov 2011

Coffee may protect against womb cancer: Study

For the study the researchers looked at coffee consumption and endometrial cancer risk in more than 67,000 women aged between 34 and 59 enrolled in the long-running Nurses' Health Study. The researchers found that women who took more than four cups of coffee a day over a 26-year period were 25 percent less likely to get the cancer.

22 Nov 2011

Is economic crunch the best birth control?

Experts feel it is the economic strain that is responsible for the U.S. birth rate decline that has been consistently falling for the third consecutive year.

22 Nov 2011

CRF to sponsor Women's Heart Health Summit

The Cardiovascular Research Foundation (CRF) will sponsor the Women's Heart Health Summit: "In Pursuit of Excellence: Improving Cardiovascular Outcomes in Women." The goal of the meeting is to examine current prevention, treatment, and key research issues to collectively identify opportunities and recommendations that will lead to improved cardiovascular outcomes in women.

22 Nov 2011

Scientists search for main culprit behind Sj-gren's syndrome

Researchers want to find the main culprit behind the dry, irritated eyes, mouth, throat, skin, nose and more afflicting 1-3 percent of the population.

22 Nov 2011

Hypertension on the rise in Canada

Hypertension in Canada is increasing, and it is projected that more than one-quarter of Canadian adults will be diagnosed with hypertension by 2012/13, according to a study in CMAJ.

22 Nov 2011

Review highlights promising interventions to improve reproductive health of women living with HIV in developing countries

An article published in the Journal of the International AIDS Society on Friday "reviews the evidence of what works to meet the sexual and reproductive health needs of women living with HIV in developing countries and includes 35 studies and evaluations of eight general interventions using various methods of implementation science from 15 countries."

21 Nov 2011

ACR denounces new breast cancer screening guidelines by CTFOPH

The American College of Radiology today denounced new breast cancer screening guidelines by the Canadian Task Force on Preventive Health (CTFOPH), which recommend against annual screening of women ages 40-49 and would extend time between screens for older women.

21 Nov 2011

Recommendations aim to enhance health and quality of life for frail and vulnerable patients in nursing home care

More than 1.5 million adults live in nursing homes in the United States, and approximately 30 percent of people will diewith a nursing home as their last place of residence. As this population continues to increase, so will the need for physicians to assist those patients with proper care and guidance in making end-of-life decisions.

21 Nov 2011

Active sex life in seniors secret to happiness

In the study of 238 married people aged 65 or older in the US. the researchers found that almost 80 per cent who had sex more than once a month were ‘very happy’ with their life in general.

21 Nov 2011

Breast cancer drug Avastin loses FDA support

According to a Food and Drug Administration (FDA) announcement last Friday, the cancer drug Avastin should not be used to treat breast cancer that has spread to other organs because it doesn't help patients enough to justify its risky side effects.

21 Nov 2011

Clinical value of OrSense NBM 200 non-invasive Hb monitor for maternal health to be presented at 4th COGI

OrSense Ltd., announced today that two oral presentations on the clinical value of its NBM 200 non-invasive hemoglobin (Hb) monitor for maternal health and anemia monitoring prior, during and post delivery of pregnant women will be presented at the 4th Asia Pacific Congress on Controversies in Obstetrics Gynecology and Infertility (COGI).

21 Nov 2011

Multi-center cabozantinib trial for hormone receptor-positive breast cancer with bone metastases initiated

Exelixis, Inc. today announced the initiation of an investigator-sponsored trial of cabozantinib in women with hormone receptor-positive breast cancer with bone metastases.

21 Nov 2011

FDA grants HDE marketing approval for BSD-2000 Hyperthermia System to treat cervical cancer

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has obtained Humanitarian Device Exemption (HDE) marketing approval for the BSD-2000 Hyperthermia System (BSD-2000) from the U.S. Food and Drug Administration.

21 Nov 2011

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

"I know I need this medicine to help lower my chance of cancer recurrence, but it makes my joints ache and stiff. It makes me feel old and I am not sure I can take this medication much longer."

19 Nov 2011

Combo hormone therapy increases risk of breast cancer in women with new-onset tenderness

The debate about using menopausal hormone therapies to relieve symptoms in post-menopausal women has been ongoing. Is the combination therapy of estrogen and progestin better or worse than just giving women estrogen alone? In women who still have a uterus (those who have not had a hysterectomy), progestin counteracts the increased risk of uterus cancer when estrogen is given alone, but at the expense of an increase in breast cancer risk compared to estrogen alone.

19 Nov 2011

Avastin drug not safe and effective for breast cancer patients: FDA Commissioner

FDA Commissioner Margaret A. Hamburg, M.D., said today she is revoking the agency's approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.

19 Nov 2011

GAVI Alliance to fund roll-out of vaccines against cervical cancer, rubella in developing countries

The GAVI Alliance "has agreed to fund the roll-out of vaccines against cervical cancer in developing countries, offering protection against a disease that kills one woman every two minutes," Reuters reports.

19 Nov 2011

FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer

Breast cancer patients, their families and advocates expressed extreme disappointment at today's Food and Drug Administration (FDA) decision to remove the anti-cancer drug Avastin from the approved medication list for treatment of late stage breast cancer.

19 Nov 2011

Women's Health News

EpiGen to collaborate with Nestl- Research Center in Switzerland

Virtues of a simple “Thank You” a day

Coffee may protect against womb cancer: Study

Is economic crunch the best birth control?

CRF to sponsor Women's Heart Health Summit

Scientists search for main culprit behind Sj-gren's syndrome

Hypertension on the rise in Canada

Review highlights promising interventions to improve reproductive health of women living with HIV in developing countries

ACR denounces new breast cancer screening guidelines by CTFOPH

Recommendations aim to enhance health and quality of life for frail and vulnerable patients in nursing home care

Active sex life in seniors secret to happiness

Breast cancer drug Avastin loses FDA support

Clinical value of OrSense NBM 200 non-invasive Hb monitor for maternal health to be presented at 4th COGI

Multi-center cabozantinib trial for hormone receptor-positive breast cancer with bone metastases initiated

FDA grants HDE marketing approval for BSD-2000 Hyperthermia System to treat cervical cancer

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

Combo hormone therapy increases risk of breast cancer in women with new-onset tenderness

Avastin drug not safe and effective for breast cancer patients: FDA Commissioner

GAVI Alliance to fund roll-out of vaccines against cervical cancer, rubella in developing countries

FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News